Sarah has been driving dsm-firmenich towards new frontiers of scientific excellence, building on the company’s legacy of industry-leading innovation. By embracing new technology to deliver breakthrough solutions in a fast-changing world, she has harnessed a multidisciplinary and global approach to research and development. Sarah combines an extensive background in biotechnology with a strong track record in ingredients and technology development for the consumer goods industry. Prior to joining Firmenich in 2018, she held pivotal roles at Ginkgo Bioworks, Intrexon and Amyris, having started her career in the field of biology and cancer therapeutics. She holds a bachelor’s in Biology from Harvey Mudd College, US, as well as a master’s in Plant Biology and a Ph.D. in Microbiology from the University of California, Berkeley, US.
